Variation in Occupational Influenza Vaccination Coverage

This article originally appeared here.
Share this content:
Variation in Occupational Influenza Vaccination Coverage
Variation in Occupational Influenza Vaccination Coverage

TUESDAY, April 4, 2017 (HealthDay News) -- There is variation in influenza vaccination coverage by industry and occupation, including among health care personnel and other occupational groups who may have first priority to receive influenza vaccination during a pandemic (tier 1), according to a study published in the April 1 issue of the American Journal of Infection Control.

Alissa C. O'Halloran, M.S.P.H., from Leidos Inc. in Atlanta, and colleagues analyzed data from 21 states using the 2013 Behavioral Risk Factor Surveillance System industry-occupation module. Influenza vaccination coverage was reported by industry and occupation groups, including health care personnel and other tier 1 groups.

The researchers found that there was variation in influenza vaccination coverage by industry and occupation, with high coverage in the health care industries and occupations. Influenza vaccination was received by approximately half of people classified as tier 1. Wide variation was seen by state in vaccination coverage among tier 1 and health care personnel groups.

"This report points to the particular industries and occupations where improvement in influenza vaccination coverage is needed," the authors write. "Prior to a pandemic event, more specificity on occupational codes to define exact industries and occupations in each tier group would be beneficial in implementing pandemic influenza vaccination programs and monitoring the success of these programs."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »